Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (28), 29797-29804
- https://doi.org/10.1074/jbc.m313989200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- COX-2: A Target for Colon Cancer PreventionAnnual Review of Pharmacology and Toxicology, 2002
- Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)?Biochemical Pharmacology, 2002
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradictionMedical Hypotheses, 2000
- PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory DrugsCell, 1999
- Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosisProceedings of the National Academy of Sciences, 1998
- Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2Journal of Biological Chemistry, 1996
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- The Catalytic Outcomes of the Constitutive and the Mitogen Inducible Isoforms of Prostaglandin H2 Synthase Are Markedly Affected by Glutathione and Glutathione Peroxidase(s)Biochemistry, 1995
- Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoidsAnalytical Biochemistry, 1990